Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Details for Australian Patent Application No. 2002340183 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Creasey, Abla A

Agent FB Rice

Pub. Number AU-B-2002340183

PCT Number PCT/US02/32624

PCT Pub. Number WO2003/032904

Priority 60/328,806 15.10.01 US

Filing date 15 October 2002

Wipo publication date 28 April 2003

Acceptance publication date 13 November 2008

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/727 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/16 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/328,806 15.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002340183

30 October 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc. 2003

13 November 2008 Application Accepted

  Published as AU-B-2002340183

12 March 2009 Standard Patent Sealed

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340184-Imidazo (4,3-E)-1,2,4-triazolo(1,5-C) pyrimidines as adenosine A2A receptor antagonists

2002340182-BUS FRAMER FOR TIME DIVISION MULTIPLEXED BUS